BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Biospecifics Technologies Corp.

Headquarters: Lynbrook, NY, United States of America
Website: N/A
Year Founded: 1990
Status: Acquired

BioCentury | Oct 20, 2020
Deals

Oct. 19 Quick Takes: Genesis, Genentech in AI drug discovery deal; plus Endo-BioSpecifics, Gemini, Catalyst-Jacobus, ONK, Venclexta  

Genesis and Genentech collaborate to identify drug candidates using AIStanford spinout and AI platform company Genesis Therapeutics Inc. entered into a collaboration agreement with the
BioCentury | Apr 20, 2017
Clinical News

Xiaflex: Ph I started

BioCentury | Dec 1, 2016
Clinical News

Xiaflex: Ph IIa data

BioCentury | Feb 22, 2016
Clinical News

Xiaflex: Phase IIb started

Items per page:
1 - 10 of 205